Back to results
US 2003/0114500 A1Published application
Nitrogen heterocycle inhibitors of aspartyl protease
AssigneeEnanta Pharmaceuticals, Inc.
InventorsGuoqiang Wang, Yat Sun Or, John Rougas, Steven Wayne Riesinger
Life of this patent
Estimating the term…
Abstract
Nitrogen heterocycles that inhibit aspartyl protease are disclosed, as are methods of treating diseases, particularly HIV, using these compounds. The compounds have the formula: 1 A representative example is: 2
Claims22
A compound of formula
- 49
- wherein
- R1 is chosen from the group consisting of C1-C20 alkyl, aryl, alkylaryl, substituted alkylaryl, C1-C10 alkoxy, C3-C10 oxaalkyl, aryloxy, substituted aryl, substituted aryloxy, heterocyclyl and heterocyclyloxy;
- R2 is chosen from the group consisting of C1-C10 hydrocarbon, substituted aryl and heterocyclyl;
- A is chosen from the group consisting of —SO2—, NHSO2—,
- 50
- 51
- is a monocyclic, bicyclic or tricyclic nitrogen heterocycle
- containing from 0
- to 3 substituents chosen from lower alkyl, lower alkoxy, lower alkylthio, hydroxy, mercapto, cyano, carboxy, lower alkoxycarbonyl, lower alkylaminocarbonyl, amino, lower alkylamino, di(lower alkyl)amino, nitro, halo and haloalkyl;
- R5, R6 and R7 are chosen independently from the group consisting of hydrogen and lower alkyl;
- D is chosen from the group consisting of —SO2—,
- 52
- E is chosen from the group consisting of C1-C10 hydrocarbon, substituted aryl, heterocyclyl and substituted heterocyclyl,
- and pharmaceutically acceptable salts thereof.
12 more elements
Dependencies are inferred from the claim text.